<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2014</study_start_year><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><study_type>Interventional</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2187848</full_dataset_link><location>China</location><study_start_month>11</study_start_month><keyword>Neoajuvant chemotherapy</keyword><keyword>Oxaliplatin</keyword><keyword>Capecitabine</keyword><repository>ECRIN MDR</repository><study_status>Not provided</study_status></additional><is_claimable>false</is_claimable><name>Efficacy and Safety of Oxaliplatin Combined With Capecitabine as Neoadjuvant Chemotherapy for Locally Advanced Colon Cancer Patients</name><description>The study aims to identify the efficacy and safety of capecitabine plus oxaliplatin (XELOX) in patients with local advanced colorectal cancer.</description><dates><creation>2014-11-15</creation></dates><accession>2187848</accession><cross_references><ClinicalTrials___gov>NCT02415829</ClinicalTrials___gov></cross_references></HashMap>